People: Bristol-Myers Squibb Co (BMY.N)
7 Mar 2014
Dr. Vicki L. Sato Ph.D., is Independent Director of Bristol-Myers Squibb Co. She has been a professor of management practice at the Harvard Business School and professor of the practice of molecular and cell biology at Harvard University since July 2005. In 2005, Dr. Sato retired as President of Vertex Pharmaceuticals Incorporated, a global biotechnology company, where she was responsible for research and development, business and corporate development, commercial operations, legal, and finance. Dr. Sato also served as Chief Scientific Officer, Senior Vice President of Research and Development, and Chair of the Scientific Advisory Board at Vertex before being named President in 2000. Dr. Sato is a Director of PerkinElmer Corporation and of Galapagos NV. During the last 5 years, she was a Director of Alnylam Pharmaceuticals, Inc. and Infinity Pharmaceuticals, Inc.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|